Moderna vaccine that targets South African variant to undergo clinical trials

Moderna has produced a vaccine that works specifically against the South African variant of coronavirus, with trials due to start in the US.

Moderna has produced a vaccine that works specifically against the South African variant of coronavirus, with trials due to start in the US.

The firm is experimenting with several potential methods of combating new variants of coronavirus, with a view to potentially offering new or booster shots.